Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Stahl

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Nature Reviews. Drug Discovery|May 30, 2023
Amplifying gene expression with RNA-targeted therapeuticsOlga Khorkova, Jack Stahl, Aswathy Joji, et al.
Frontiers in Molecular Biosciences|October 17, 2022
Natural antisense transcripts as drug targetsOlga Khorkova, Jack Stahl, Aswathy Joji, et al.
Expert Opinion on Drug Discovery|July 19, 2023
Long non-coding RNA-targeting therapeutics: discovery and development updateOlga Khorkova, Jack Stahl, Aswathy Joji, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentJack Stahl, Aswathy Joji, Elianny Perozo Rojas, et al.
Elife|January 17, 2022
A human-based multi-gene signature enables quantitative drug repurposing for metabolic diseaseJames A Timmons, Andrew Anighoro, Robert J Brogan, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Nature Reviews. Drug Discovery|May 30, 2023
Amplifying gene expression with RNA-targeted therapeuticsOlga Khorkova, Jack Stahl, Aswathy Joji, et al.
Frontiers in Molecular Biosciences|October 17, 2022
Natural antisense transcripts as drug targetsOlga Khorkova, Jack Stahl, Aswathy Joji, et al.
Expert Opinion on Drug Discovery|July 19, 2023
Long non-coding RNA-targeting therapeutics: discovery and development updateOlga Khorkova, Jack Stahl, Aswathy Joji, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentJack Stahl, Aswathy Joji, Elianny Perozo Rojas, et al.
Elife|January 17, 2022
A human-based multi-gene signature enables quantitative drug repurposing for metabolic diseaseJames A Timmons, Andrew Anighoro, Robert J Brogan, et al.
Pageof 1